Equitec Proprietary Markets’s Kite Pharma, Inc. KITE Stock Holding History
Bought
Maintained
Sold
Equitec Proprietary Markets's KITE Position: Q4 2017 in Review
Equitec Proprietary Markets sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 153,610 shares — an estimated $27.6M sold.
Equitec Proprietary Markets first reported a position in KITE in Q3 2017 and held it in 1 quarter. The position peaked at $27.6M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.
- Equitec Proprietary Markets reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
- Equitec Proprietary Markets sold 153,610 Kite Pharma, Inc. shares in Q4 2017, an estimated $27.6M.
- Equitec Proprietary Markets first reported a position in Kite Pharma, Inc. in Q3 2017 and held it in 1 quarter.
- Equitec Proprietary Markets's Kite Pharma, Inc. position peaked at $27.6M in Q3 2017.
- 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.
Based on Equitec Proprietary Markets's 13F filing for Q4 2017, filed 24 Jan 2018.